{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:26:05Z","timestamp":1795033565205,"version":"4.10.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The guanosine analog AT-527 represents a promising candidate against Severe Acute Respiratory Syndrome coronavirus type 2 (SARS-CoV-2). AT-527 recently entered phase III clinical trials for the treatment of COVID-19. Once in cells, AT-527 is converted into its triphosphate form, AT-9010, that presumably targets the viral RNA-dependent RNA polymerase (RdRp, nsp12), for incorporation into viral RNA. Here we report a 2.98\u2009\u00c5 cryo-EM structure of the SARS-CoV-2 nsp12-nsp7-nsp8\n                    <jats:sub>2<\/jats:sub>\n                    -RNA complex, showing AT-9010 bound at three sites of nsp12. In the RdRp active-site, one AT-9010 is incorporated at the 3\u2032 end of the RNA product strand. Its modified ribose group (2\u2032-fluoro, 2\u2032-methyl) prevents correct alignment of the incoming NTP, in this case a second AT-9010, causing immediate termination of RNA synthesis. The third AT-9010 is bound to the N-terminal domain of nsp12 - known as the NiRAN. In contrast to native NTPs, AT-9010 is in a flipped orientation in the active-site, with its guanine base unexpectedly occupying a previously unnoticed cavity. AT-9010 outcompetes all native nucleotides for NiRAN binding, inhibiting its nucleotidyltransferase activity. The dual mechanism of action of AT-527 at both RdRp and NiRAN active sites represents a promising research avenue against COVID-19.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-28113-1","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T06:06:03Z","timestamp":1643781963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-8247","authenticated-orcid":false,"given":"Ashleigh","family":"Shannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Fattorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhawna","family":"Sama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Selisko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Feracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Falcou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Gauffre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila","family":"El Kazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Delpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Decroly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6108-6966","authenticated-orcid":false,"given":"Karine","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4181-592X","authenticated-orcid":false,"given":"C\u00e9cilia","family":"Eydoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Guillemot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S.","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"La Colla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2186-7466","authenticated-orcid":false,"given":"Kai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Sommadossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3452-1643","authenticated-orcid":false,"given":"Yingxiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8351-4992","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Ferron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4924-1991","authenticated-orcid":false,"given":"Bruno","family":"Canard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"28113_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0092-8674(02)01110-8","volume":"111","author":"Y Tao","year":"2002","unstructured":"Tao, Y., Farsetta, D. L., Nibert, M. L. & Harrison, S. C. RNA synthesis in a cage\u2013structural studies of reovirus polymerase lambda3. Cell 111, 733\u2013745 (2002).","journal-title":"Cell"},{"key":"28113_CR2","doi-asserted-by":"publisher","unstructured":"Peersen, O. B. A comprehensive superposition of viral polymerase structures. Viruses 11, https:\/\/doi.org\/10.3390\/v11080745 (2019).","DOI":"10.3390\/v11080745"},{"key":"28113_CR3","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1073\/pnas.0508200103","volume":"103","author":"E Minskaia","year":"2006","unstructured":"Minskaia, E. et al. Discovery of an RNA virus 3\u2032->5\u2032 exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc. Natl Acad. Sci. USA 103, 5108\u20135113 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28113_CR4","doi-asserted-by":"publisher","first-page":"12135","DOI":"10.1128\/JVI.01296-07","volume":"81","author":"LD Eckerle","year":"2007","unstructured":"Eckerle, L. D., Lu, X., Sperry, S. M., Choi, L. & Denison, M. R. High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants. J. Virol. 81, 12135\u201312144 (2007).","journal-title":"J. Virol."},{"key":"28113_CR5","doi-asserted-by":"publisher","first-page":"9372","DOI":"10.1073\/pnas.1201130109","volume":"109","author":"M Bouvet","year":"2012","unstructured":"Bouvet, M. et al. RNA 3\u2032-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10\/nsp14 exoribonuclease complex. Proc. Natl Acad. Sci. USA 109, 9372\u20139377 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28113_CR6","doi-asserted-by":"publisher","first-page":"E162","DOI":"10.1073\/pnas.1718806115","volume":"115","author":"F Ferron","year":"2018","unstructured":"Ferron, F. et al. Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA. Proc. Natl Acad. Sci. USA 115, E162\u2013E171 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28113_CR7","doi-asserted-by":"publisher","unstructured":"Good, S. S. et al. AT-527, a double prodrug of a guanosine nucleotide analog, is a potent inhibitor of SARS-CoV-2 in vitro and a promising oral antiviral for treatment of COVID-19. Antimicrob. Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.02479-20 (2021).","DOI":"10.1128\/AAC.02479-20"},{"key":"28113_CR8","doi-asserted-by":"publisher","first-page":"e0227104","DOI":"10.1371\/journal.pone.0227104","volume":"15","author":"SS Good","year":"2020","unstructured":"Good, S. S., Moussa, A., Zhou, X.-J., Pietropaolo, K. & Sommadossi, J.-P. Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus. PLoS ONE 15, e0227104 (2020).","journal-title":"PLoS ONE"},{"key":"28113_CR9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.7150\/thno.48342","volume":"11","author":"YJ Han","year":"2021","unstructured":"Han, Y. J. et al. Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials. Theranostics 11, 1207\u20131231 (2021).","journal-title":"Theranostics"},{"key":"28113_CR10","doi-asserted-by":"publisher","first-page":"204020661875643","DOI":"10.1177\/2040206618756430","volume":"26","author":"CB Dousson","year":"2018","unstructured":"Dousson, C. B. Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infection. Antivir. Chem. Chemother. 26, 2040206618756430 (2018).","journal-title":"Antivir. Chem. Chemother."},{"key":"28113_CR11","doi-asserted-by":"publisher","first-page":"12910","DOI":"10.1074\/jbc.REV120.013930","volume":"295","author":"E Hartenian","year":"2020","unstructured":"Hartenian, E. et al. The molecular virology of coronaviruses. J. Biol. Chem. 295, 12910\u201312934 (2020).","journal-title":"J. Biol. Chem."},{"key":"28113_CR12","doi-asserted-by":"publisher","first-page":"8416","DOI":"10.1093\/nar\/gkv838","volume":"43","author":"KC Lehmann","year":"2015","unstructured":"Lehmann, K. C. et al. Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses. Nucleic Acids Res. 43, 8416\u20138434 (2015).","journal-title":"Nucleic Acids Res."},{"key":"28113_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.cell.2018.08.046","volume":"175","author":"A Sreelatha","year":"2018","unstructured":"Sreelatha, A. et al. Protein AMPylation by an evolutionarily conserved pseudokinase. Cell 175, 809\u2013821.e19 (2018).","journal-title":"Cell"},{"key":"28113_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s42004-021-00476-4","volume":"4","author":"BJ Conti","year":"2021","unstructured":"Conti, B. J., Leicht, A. S., Kirchdoerfer, R. N. & Sussman, M. R. Mass spectrometric based detection of protein nucleotidylation in the RNA polymerase of SARS-CoV-2. Commun. Chem. 4, 41 (2021).","journal-title":"Commun. Chem."},{"key":"28113_CR15","doi-asserted-by":"publisher","unstructured":"Slanina, H. et al. Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit. Proc Natl Acad Sci USA 118, https:\/\/doi.org\/10.1073\/pnas.2022310118 (2021).","DOI":"10.1073\/pnas.2022310118"},{"key":"28113_CR16","doi-asserted-by":"publisher","unstructured":"Shannon, A. et al. Protein-primed RNA synthesis in SARS-CoVs and structural basis for inhibition by AT-527. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.03.23.436564 (2021).","DOI":"10.1101\/2021.03.23.436564"},{"key":"28113_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2020.11.016","volume":"184","author":"L Yan","year":"2021","unstructured":"Yan, L. et al. Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex reveals an intermediate state in cap synthesis. Cell 184, 184\u2013193.e10 (2021).","journal-title":"Cell"},{"key":"28113_CR18","doi-asserted-by":"publisher","first-page":"E3900","DOI":"10.1073\/pnas.1323705111","volume":"111","author":"L Subissi","year":"2014","unstructured":"Subissi, L. et al. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities. Proc. Natl Acad. Sci. USA 111, E3900\u2013E3909 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28113_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10280-3","volume":"10","author":"RN Kirchdoerfer","year":"2019","unstructured":"Kirchdoerfer, R. N. & Ward, A. B. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat. Commun. 10, 2342 (2019).","journal-title":"Nat. Commun."},{"key":"28113_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.abb7498","volume":"368","author":"Y Gao","year":"2020","unstructured":"Gao, Y. et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science 368, 779\u2013782 (2020).","journal-title":"Science"},{"key":"28113_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","volume":"182","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. Structural basis for RNA replication by the SARS-CoV-2 polymerase. Cell 182, 417\u2013428.e13 (2020).","journal-title":"Cell"},{"key":"28113_CR22","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1126\/science.abc1560","volume":"368","author":"W Yin","year":"2020","unstructured":"Yin, W. et al. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science 368, 1499\u20131504 (2020).","journal-title":"Science"},{"key":"28113_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","volume":"584","author":"HS Hillen","year":"2020","unstructured":"Hillen, H. S. et al. Structure of replicating SARS-CoV-2 polymerase. Nature 584, 154\u2013156 (2020).","journal-title":"Nature"},{"key":"28113_CR24","doi-asserted-by":"publisher","unstructured":"Malone, B. et al. Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex. Proc Natl Acad Sci USA. 118, https:\/\/doi.org\/10.1073\/pnas.2102516118 (2021).","DOI":"10.1073\/pnas.2102516118"},{"key":"28113_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.virusres.2017.01.026","volume":"234","author":"OB Peersen","year":"2017","unstructured":"Peersen, O. B. Picornaviral polymerase structure, function, and fidelity modulation. Virus Res. 234, 4\u201320 (2017).","journal-title":"Virus Res."},{"key":"28113_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18463-z","volume":"11","author":"A Shannon","year":"2020","unstructured":"Shannon, A. et al. B. Canard, rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis. Nat. Commun. 11, 4682 (2020).","journal-title":"Nat. Commun."},{"key":"28113_CR27","doi-asserted-by":"publisher","first-page":"22505","DOI":"10.1073\/pnas.1007626107","volume":"107","author":"P Gong","year":"2010","unstructured":"Gong, P. & Peersen, O. B. Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase. Proc. Natl Acad. Sci. USA 107, 22505\u201322510 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28113_CR28","doi-asserted-by":"publisher","unstructured":"Naydenova, K. et al. Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP. Proc Natl Acad Sci USA. 118, https:\/\/doi.org\/10.1073\/pnas.2021946118 (2021).","DOI":"10.1073\/pnas.2021946118"},{"key":"28113_CR29","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1126\/science.1259210","volume":"347","author":"TC Appleby","year":"2015","unstructured":"Appleby, T. C. et al. Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase. Science 347, 771\u2013775 (2015).","journal-title":"Science"},{"key":"28113_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20542-0","volume":"12","author":"G Kokic","year":"2021","unstructured":"Kokic, G. et al. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nat. Commun. 12, 279 (2021).","journal-title":"Nat. Commun."},{"key":"28113_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00928361","volume":"140","author":"TW Traut","year":"1994","unstructured":"Traut, T. W. Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem. 140, 1\u201322 (1994).","journal-title":"Mol. Cell. Biochem."},{"key":"28113_CR32","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.cell.2020.07.033","volume":"182","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex. Cell 182, 1560\u20131573.e13 (2020).","journal-title":"Cell"},{"key":"28113_CR33","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/j.1460-2075.1995.tb07082.x","volume":"14","author":"RM Xu","year":"1995","unstructured":"Xu, R. M., Carmel, G., Sweet, R. M., Kuret, J. & Cheng, X. Crystal structure of casein kinase-1, a phosphate-directed protein kinase. EMBO J. 14, 1015\u20131023 (1995).","journal-title":"EMBO J."},{"key":"28113_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"28113_CR35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"28113_CR36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D. Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. D. Struct. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28113-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28113-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28113-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T10:59:28Z","timestamp":1669287568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28113-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28113"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28113-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-624370\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2021.03.23.436564","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"27 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.G., A.M., K.L., and J.P.S. are employees of ATEA Pharmaceuticals, Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"621"}}